Skip to content
1887

JMM Case Reports JMM Case Reports

Volume 1, Issue 4

R77Q and Q3R HIV1‐VPR mutations in an otherwise asymptomatic 5‐year‐old child with repeated ear infections Open Access

Abstract

Introduction:

Viral protein R (Vpr) of human immunodeficiency virus type 1 (HIV‐1) has been described as being involved in the progression of AIDS, and specific mutations are associated with long‐term non‐progressor patients.

Case presentation:

We describe the case of a child with repeated ear infections who was otherwise healthy. The patient, a 5‐year‐old boy, was HIV‐1 positive and the viral load at admission was 1 073 899 RNA copies ml and 0 % CD4 lymphocytes. A detailed study of the gene sequence of the child revealed mutations leading to amino acid substitutions at positions 3 and 77.

Conclusion:

The case reported provides clinical support of previous findings that show that the R77Q and Q3R HIV‐1 Vpr variants are associated with patients with delayed disease progression.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): AIDS/HIV‐1 , asymptomatic , HAART , long‐term non‐progressor and Vpr mutation
© 2014 The Authors
  • This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/).
Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.002709
2014-12-01
2025-05-17
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/1/4/jmmcr002709.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.002709&mimeType=html&fmt=ahah

References

  1. Andersen J.L, Le Rouzic E, Planelles V. 2008; HIV‐1 Vpr: mechanisms of G2 arrest and apoptosis. Exp Mol Pathol 85:2–10 [CrossRef]
     [Google Scholar]
  2. Bickel M, Lassmann C, Wieters I, Doerr H.W, Herrmann E, Wicker S, Brodt H.R, Stephan C, Allwinn R, Jung O. 2013; Immune response after a single dose of the 2010/11 trivalent, seasonal influenza vaccine in HIV‐1‐infected patients and healthy controls. HIV Clin Trials 14:175–184 [CrossRef]
     [Google Scholar]
  3. CDC 2014 Guide for HIV/AIDS Clinical Care. http://aidsetc.org/guide/contents
  4. Chang F, Re F, Sebastian S, Sazer S, Luban J. 2004; HIV‐1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomes. Mol Biol Cell 15:1793–1801 [CrossRef]
     [Google Scholar]
  5. Chen M, Elder R.T, Yu M, O’Gorman M.G, Selig L, Benarous R, Yamamoto A, Zhao Y. 1999; Mutational analysis of Vpr‐induced G2 arrest, nuclear localization, and cell death in fission yeast. J Virol 73:3236–3245
     [Google Scholar]
  6. Di Marzio P, Choe S, Ebright M, Knoblauch R, Landau N.R. 1995; Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol 69:7909–7916
     [Google Scholar]
  7. Fischer A, Lejczak C, Lambert C, Roman F, Servais J, Karita E, Allen S, Schmi t.J.C, Arendt V. 2004; Is the Vpr R77Q mutation associated with long‐term non‐progression of HIV infection?. AIDS 18:1346–1347 [CrossRef]
     [Google Scholar]
  8. Gaardbo J.C, Hartling H.J, Gerstoft J, Nielsen S.D. 2012; Thirty years with HIV infection‐nonprogression is still puzzling: lessons to be learned from controllers and long‐term non‐progressors. AIDS Res Treat 2012:161584
     [Google Scholar]
  9. Henklein P, Bruns K, Sherman M.P, Tessmer U, Licha K, Kopp J, de Noronha C.M, Greene W.C, Wray V, Schubert U. 2000; Functional and structural characterization of synthetic HIV‐1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J Biol Chem 275:32016–32026 [CrossRef]
     [Google Scholar]
  10. Hoaré S. 2003; HIV infection in children‐impact upon ENT doctors. Int J Pediatr Otorhinolaryngol 67:S85–S90 [CrossRef]
     [Google Scholar]
  11. Jacotot E, Ravagnan L, Loeffler M, Ferri K.F, Vieira H.L, Zamzami N, Costantini P, Druillennec S, Hoebeke J. other authors 2000; The HIV‐1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med 191:33–46 [CrossRef]
     [Google Scholar]
  12. Jacquot G, Le R.E, Maidou‐Peindara P, Maizy M, Lefrere J.J, Daneluzzi V, Monteiro‐Filho C.M.R, Hong D, Planelles V, Morand‐Joubert L, Benichou S. 2009; Characterization of the molecular determinants of primary HIV‐1 Vpr proteins: impact of the Q65R and R77Q substitutions on Vpr functions. PLoS One 4:e7514 [CrossRef]
     [Google Scholar]
  13. Jowett J.B, Xie Y.M, Chen I.S. 1999; The presence of human immunodeficiency virus type 1 Vpr correlates with a decrease in the frequency of mutations in a plasmid shuttle vector. J Virol 73:7132–7137
     [Google Scholar]
  14. Kogan M, Rappaport J. 2011; HIV‐1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology 8:25 [CrossRef]
     [Google Scholar]
  15. Le Doaré K, Bland R, Newell M.L. 2012; Neurodevelopment in children born to HIV‐infected mothers by infection and treatment status. Pediatrics 130:e1326–e1344 [CrossRef]
     [Google Scholar]
  16. Lopez O.L, Becker J.T, Dew M.A, Banks G, Dorst S.K, McNeil M. 1994; Speech motor control disorder after HIV infection. Neurology 44:2187–2189 [CrossRef]
     [Google Scholar]
  17. Lum J.J, Cohen O.J, Nie Z, Weaver J.G, Gomez T.S, Yao X.J, Lynch D, Pilon A.A, Hawley N. other authors 2003; Vpr R77Q is associated with long‐term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest 111:1547–1554 [CrossRef]
     [Google Scholar]
  18. Mologni D, Citterio P, Menzaghi B, Zanone P.B, Riva C, Broggini V, Sinicco A, Milazzo L, Adorni F. other authors 2006; Vpr and HIV‐1 disease progression: R77Q mutation is associated with long‐term control of HIV‐1 infection in different groups of patients. AIDS 20:567–574 [CrossRef]
     [Google Scholar]
  19. Mphahlele M.J, Mda S. 2012; Immunising the HIV‐infected child: a view from sub‐Saharan Africa. Vaccine 30:(Suppl.3)C61–C65 [CrossRef]
     [Google Scholar]
  20. Poropatich K, Sullivan D.J Jr. 2011; Human immunodeficiency virus type 1 long‐term non‐progressors: the viral, genetic and immunological basis for disease non‐progression. J Gen Virol 92:247–268 [CrossRef]
     [Google Scholar]
  21. Rajan D, Wildum S, Rucker E, Schindler M, Kirchhoff F. 2006; Effect of R77Q, R77A and R80A changes in Vpr on HIV‐1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo. AIDS 20:831–836 [CrossRef]
     [Google Scholar]
  22. Rogel M.E, Wu L.I, Emerman M. 1995; The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J Virol 69:882–888
     [Google Scholar]
  23. Romani B, Engelbrecht S. 2009; Human Immunodeficiency virus type 1 Vpr: functions and molecular interactions. J Gen Virol 90:1795–1805 [CrossRef]
     [Google Scholar]
  24. Roshal M, Zhu Y, Planelles V. 2001; Apoptosis in AIDS. Apoptosis 6:103–116 [CrossRef]
     [Google Scholar]
  25. Sawaya B.E, Khalili K, Gordon J, Taube R, Amini S. 2000; Cooperative interaction between HIV‐1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J Biol Chem 275:35209–35214 [CrossRef]
     [Google Scholar]
  26. Somasundaran M, Sharkey M, Brichacek B, Luzuriaga K, Emerman M, Sullivan J.L, Stevenson M. 2002; Evidence for a cyto‐pathogenicity determinant in HIV‐1 Vpr. Proc Natl Acad Sci U S A 99:9503–9508 [CrossRef]
     [Google Scholar]
  27. Sörgel S, Fraedrich K, Votteler J, Thomas M, Stamminger T, Schubert U. 2012; Perinuclear localization of the HIV‐1 regulatory protein Vpr is important for induction of G2‐arrest. Virology 432:444–451 [CrossRef]
     [Google Scholar]
  28. Vodicka M.A, Koepp D.M, Silver P.A, Emerman M. 1998; HIV‐1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev 12:175–185 [CrossRef]
     [Google Scholar]
  29. Wolters P.L, Brouwers P, Civitello L, Moss H.A. 1997; Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24‐month follow‐up study. AIDS 11:1135–1144 [CrossRef]
     [Google Scholar]
  30. Woods S.P, Iudicello J.E, Dawson M.S, Weber E, Grant I, Letendre S.L. HIV Neurobehavioral Research Center (HNRC) Group 2010; HIV‐associated deficits in action (verb) generation may reflect astrocytosis. J Clin Exp Neuropsychol 32:522–527 [CrossRef]
     [Google Scholar]
  31. Yao X.J, Subbramanian R.A, Rougeau N, Boisvert F, Bergeron D, Cohen E.A. 1995; Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N‐terminal α‐helical structure in Vpr nuclear localization and virion incorporation. J Virol 69:7032–7044
     [Google Scholar]
  32. Zhao Y, Chen M, Wang B, Yang J, Elder R.T, Song X.Q, Yu M, Saksena N.K. 2002; Functional conservation of HIV‐1 Vpr and variability in a mother–child pair of long‐term non‐progressors. Virus Res 89:103–121 [CrossRef]
     [Google Scholar]
/content/journal/jmmcr/10.1099/jmmcr.0.002709
Loading
R77Q and Q3R HIV1‐VPR mutations in an otherwise asymptomatic 5‐year‐old child with repeated ear infections
JMM Case Rep 1, e002709 (2014); https://doi.org/10.1099/jmmcr.0.002709
/content/journal/jmmcr/10.1099/jmmcr.0.002709
/content/journal/jmmcr/10.1099/jmmcr.0.002709
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error